Group 1 - The Extraordinary General Meeting (AGM) of Fingerprint Cards AB is scheduled for August 18, 2025, at 10:00 a.m. in Stockholm [1] - Shareholders can participate in the AGM either in person, through a proxy, or by postal voting [2] - Shareholders must register their shares in their own name by August 8, 2025, to be eligible to participate [3] Group 2 - Shareholders wishing to attend in person or via proxy must notify the company by August 12, 2025 [4] - A proxy form is available on the company's website, and a power of attorney must be provided for proxy voting [5] - Postal voting can be conducted electronically, via email, or by regular mail, with a deadline of August 12, 2025 [6][8][9] Group 3 - The proposed agenda for the AGM includes the election of a Chairman, approval of the voting list, and several resolutions regarding share structure [13][14] - The Board of Directors proposes to revoke a previous resolution regarding a reverse share split due to technical issues [16][17] - A new proposal for a reverse share split is suggested, consolidating 2,000 existing shares into one new share, which will reduce the total number of shares significantly [23] Group 4 - The total number of shares in the company is currently 15,175,375,766, with 15,246,250,766 total votes [31] - The company holds 3,800,000 of its own B-shares [31] - Documentation related to the AGM will be available on the company's website three weeks prior to the meeting [30]

Core Viewpoint - Fingerprint Cards AB (FPC) has announced a revised plan for a reverse share split due to unforeseen technical issues that prevented the initial execution of the split [1][2][4]. Group 1: Reverse Share Split Details - The initial reverse share split was halted because the estimated number of shares required for rounding up shareholders' holdings was significantly underestimated, leading to potential costs for the company [2]. - The Board of Directors proposed a new method called the "rounding down-method," where excess Class B shares will be transferred to the company's ownership, and shareholders will receive cash compensation for any excess shares [3]. - The reverse share split will occur at a ratio of 1:2,000, reducing the total number of shares from 15,175,375,766 to 7,587,687 shares, while maintaining class-specific rights and characteristics [3][4]. Group 2: Company Background and Future Plans - The reverse share split is part of FPC's strategy to align its operational and financial progress with growth initiatives and to achieve an appropriate number of shares [4]. - The company plans to execute the reverse share split in the third quarter of 2025, with further details to be announced in a separate press release [4].

Core Viewpoint - Fingerprint Cards AB (FPC) has encountered unforeseen technical issues that have delayed the planned reverse share split, which was initially set for July 11, 2025 [1][2]. Group 1: Reverse Share Split Details - The reverse share split will occur at a ratio of 1:2,000, meaning shareholders will receive one new share for every two thousand existing shares [4]. - After the reverse share split, the total number of shares will decrease from 15,175,375,766 to 7,587,687 shares, and the total votes will decrease from 15,246,250,766 to 7,623,120 votes [4]. - The Board of Directors has proposed a revised method for the reverse share split, utilizing a "rounding down-method" to avoid economic loss for shareholders [3]. Group 2: Financial and Operational Context - The reverse share split is part of FPC's strategy to align its share structure with its operational and financial progress, facilitating continued growth initiatives [5]. - The company intends to execute the reverse share split in the third quarter of 2025, with further details to be announced in a separate press release [5]. Group 3: Shareholder Implications - Shareholders holding fewer than 2,000 shares will have their holdings rounded down to zero and will no longer be shareholders in FPC [7]. - Eligible shareholders will receive cash compensation for any excess shares after the reverse share split [3].

Core Points - Fusion Fuel Green PLC will hold its Annual General Meeting (AGM) on June 25, 2025, at 2:00 PM Dublin time [1] - Shareholders are encouraged to review the Notice of AGM, which includes six proposals for approval by the Board of Directors [2] - A key proposal is to authorize a reverse share split of the Company's Class A Ordinary Shares at a ratio between 4-to-1 and 40-to-1 to comply with Nasdaq's minimum bid price requirement of $1.00 per share [3] - CEO John-Paul Backwell emphasized that obtaining shareholder approval for the reverse share split will demonstrate the Company's progress towards compliance with Nasdaq listing requirements and long-term sustainability [4] - Fusion Fuel Green PLC is an energy company providing engineering, advisory, and fuel distribution solutions, actively expanding into new sectors and geographies to support energy transition [5]

Core Points - ARB IOT Group Limited announced a one-for-fifteen reverse share split approved by shareholders and the board of directors [1] - The reverse share split aims to increase the per share trading price to meet the $1.00 minimum bid price requirement for NASDAQ listing [3] Company Overview - ARB IOT Group Limited provides complete solutions for the integration of Internet of Things (IoT) systems and devices, covering design to project deployment [4] - The company offers a wide range of IoT systems and services, including system integration and support, delivering holistic solutions with full turnkey deployment [4]

The Board of Directors of Fingerprint Cards AB ("FPC" or "the Company") has decided to propose to the Annual General Meeting a reverse share split of the Company's shares, whereby Class A and Class B shares will be subject to the reverse split at a ratio of 2,000:1, resulting in one (1) share for every two thousand (2,000) existing shares of the same class, with all class-specific rights and characteristics remaining unchanged (the “Reverse Share Split”). The Reverse Share Split is intended to be carried ou ...

Core Points - Top KingWin Ltd will implement a reverse share split of its outstanding class A ordinary shares at a ratio of 1-for-25, effective May 5, 2025 [1][2][4] - The reverse share split aims to help the company regain compliance with Nasdaq's minimum bid price requirement of $1.00 per share [2][4] - Following the split, the number of issued and outstanding shares will decrease from approximately 180 million to about 7.2 million [4] Company Overview - Top KingWin provides services primarily to entrepreneurs and executives in small and medium-sized enterprises in China, including corporate business training, consulting services, advisory and transaction services, and sales of devices for AI data collection and analysis [7]

Core Viewpoint - WORK Medical Technology Group LTD has received a notification from Nasdaq regarding non-compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market [1][2]. Company Compliance Status - Nasdaq Listing Rule 5550(a)(2) mandates a minimum bid price of US$1.00 per share, and the company failed to meet this requirement for 30 consecutive business days from February 24, 2025, to April 4, 2025 [2]. - The company has until October 6, 2025, to regain compliance by ensuring its Class A ordinary shares have a closing bid price of at least US$1.00 for a minimum of 10 consecutive business days [3]. Business Operations - The receipt of the Notification Letter does not impact the company's business operations [3]. - The company plans to monitor its share price and may consider options such as a reverse share split to regain compliance with Nasdaq's minimum bid price requirement [4]. Company Overview - WORK Medical Technology Group LTD, through its subsidiary, develops and manufactures Class I and II medical devices, with a diverse product portfolio of 21 products, including customized masks and medical consumables [5]. - The company's products are sold in 34 provincial-level regions in China and in over 30 countries worldwide, with 17 products registered with the U.S. Food and Drug Administration [5].